• Maplight Therapeutics CEO Christopher A. Kroeger reported sales totaling 68,511 shares of Voting Common Stock in transactions dated May 7-11.
• Sales were executed at weighted average prices ranging from $27.48 to $30.56.
• Directly held shares fell to 1,512,329 following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001658918-26-000010), on May 11, 2026, and is solely responsible for the information contained therein.